Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis
Diagnostics · 21.06.2024 · 14 (13) · 1317
DOI: 10.3390/diagnostics14131317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 21.06.2024. Verfasst von Nobuharu Tamaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japanese Ministry of Health, Welfare and Labor, Japanese Ministry of Health, Labor and Welfare.
Abstract (Originalsprache)
Background and aims: The enhanced liver fibrosis (ELF) score is a blood test that combines three markers linked to liver fibrosis. The utility of the ELF score has been demonstrated primarily in Western countries, but whether it is useful in areas with a high number of elderly people suffering from chronic liver disease has yet to be determined.
Methods
This is a prospective study that included 373 consecutive patients who underwent a liver biopsy and had their ELF score measured on the same day. The diagnostic accuracy of the ELF score for liver fibrosis and the effect of age on the ELF score were investigated.
Results
The median (interquartile) ELF scores in F0, F1, F2, F3, and F4 are 8.7 (8.2–9.2), 9.3 (8.8–10.0), 10.1 (9.4–10.7), 10.7 (9.9–11.2), and 12.0 (11.2–12.7), respectively. ELF scores increased with increasing liver fibrosis stage (p < 0.001). The diagnostic accuracy of the ELF score and FIB-4 for significant fibrosis (F2–4) and advanced fibrosis (F3–4) was comparable, but the ELF score had a higher diagnostic accuracy for cirrhosis (F4) than FIB-4. When patients were stratified by age of 60 years, the median ELF score did not differ by age in F2, F3, and F4. However, the median FIB-4 increased in patients with ≥60 years compared to those with
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-8610, Japan.
ORCID-Profile: Nobuharu Tamaki, Kenta Takaura, Yutaka Yasui
Förderung
- Japan Agency for Medical Research and Development
- Japanese Ministry of Health, Welfare and Labor
- Japanese Ministry of Health, Labor and Welfare
Zitieren
APA
Tamaki, N., Takaura, K., Higuchi, M., Yasui, Y., Itakura, J., Tsuchiya, K., Nakanishi, H., Izumi, N., & Kurosaki, M. (2024). Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis. Diagnostics, 14(13), 1317. https://doi.org/10.3390/diagnostics14131317
Vancouver
Tamaki N, Takaura K, Higuchi M, Yasui Y, Itakura J, Tsuchiya K, et al. Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis. Diagnostics. 2024;14(13):1317. doi:10.3390/diagnostics14131317
BibTeX
@article{Tamaki2024,
author = {Tamaki, Nobuharu and Takaura, Kenta and Higuchi, Mayu and Yasui, Yutaka and Itakura, Jun and Tsuchiya, Kaoru and Nakanishi, Hiroyuki and Izumi, Namiki and Kurosaki, Masayuki},
title = {Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {13},
pages = {1317},
doi = {10.3390/diagnostics14131317}
}
EUVIMED